Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression signatures for lung adenocarcinoma

ABSTRACT: Gene expression signatures for lung adenocarcinoma

PROVIDER: PRJNA590980 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Lung adenocarcinoma UNC0638 gene expression

Project description:Lung adenocarcinoma UNC0638 gene expression

| PRJNA491480 | ENA

Gene expression signatures for lung adenocarcinoma

Project description:We used whole genome microarray expression profiling as a discovery platform to identify genes through 7 pairs lung adenocarcinoma tissues and normal tissues

2020-08-17 | GSE140797 | GEO

Epithelial signatures of chemical-induced lung adenocarcinoma

Project description:Epithelial signatures of chemical-induced lung adenocarcinoma

| PRJNA375075 | ENA

USP12-induced gene expression in lung adenocarcinoma cells

Project description:USP12-induced gene expression in lung adenocarcinoma cells

| PRJNA659656 | ENA

Gene expression from mouse lung adenocarcinoma-associated macrophages

Project description:Gene expression from mouse lung adenocarcinoma-associated macrophages

| PRJNA471545 | ENA

Ito2019 - gefitnib resistance of lung adenocarcinoma caused by MET amplification

Project description:The model is based on publication: Mathematical analysis of gefitinib resistance of lung adenocarcinoma caused by MET amplification Abstract: Gefitinib, one of the tyrosine kinase inhibitors of epidermal growth factor receptor (EGFR), is effective for treating lung adenocarcinoma harboring EGFR mutation; but later, most cases acquire a resistance to gefitinib. One of the mechanisms conferring gefitinib resistance to lung adenocarcinoma is the amplification of the MET gene, which is observed in 5–22% of gefitinib-resistant tumors. A previous study suggested that MET amplification could cause gefitinib resistance by driving ErbB3-dependent activation of the PI3K pathway. In this study, we built a mathematical model of gefitinib resistance caused by MET amplification using lung adenocarcinoma HCC827-GR (gefitinib resistant) cells. The molecular reactions involved in gefitinib resistance consisted of dimerization and phosphorylation of three molecules, EGFR, ErbB3, and MET were described by a series of ordinary differential equations. To perform a computer simulation, we quantified each molecule on the cell surface using flow cytometry and estimated unknown parameters by dimensional analysis. Our simulation showed that the number of active ErbB3 molecules is around a hundred-fold smaller than that of active MET molecules. Limited contribution of ErbB3 in gefitinib resistance by MET amplification is also demonstrated using HCC827-GR cells in culture experiments. Our mathematical model provides a quantitative understanding of the molecular reactions underlying drug resistance.

2024-09-02 | BIOMD0000000827 | BioModels

Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer

Project description:RATIONALE: Diagnostic imaging procedures, such as fludeoxyglucose F 18 PET, may be effective in detecting cancer or recurrence of cancer, or premalignant polyps. PURPOSE: This clinical trial is studying fludeoxyglucose F 18-PET imaging to see how well it works in determining protein and gene expression signatures in patients with premalignant polyps or colon cancer.

| 2045806 | ecrin-mdr-crc

RNAseq carcinogen induced signatures in lung adenocarcinoma cell lines

Project description:RNAseq carcinogen induced signatures in lung adenocarcinoma cell lines

| PRJNA521051 | ENA

DNA methylation and gene expression in lung adenocarcinoma

Project description:This SuperSeries is composed of the following subset Series: GSE32861: Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression GSE32863: Gene expression analysis of lung adenocarcinoma and matched adjacent non-tumor lung tissue GSE32866: Genome-scale DNA methylation profiling of lung adenocarcinoma: validation using Ontario Tumor Bank samples Refer to individual Series

2012-03-21 | E-GEOD-32867 | biostudies-arrayexpress

Gene expression from mouse lung adenocarcinoma-associated CD4 cells

Project description:Gene expression from mouse lung adenocarcinoma-associated CD4 cells

| PRJNA505151 | ENA